Equity Profile

DVA

DaVita Inc.

Health CareHealth Care Services$11.4B

Aug5Wed

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

DaVita Inc. is a leading provider of kidney care services, primarily through dialysis centers....

Key Metrics to Watch

EPS (Earnings Per Share)

EPS is a key indicator of profitability and helps investors gauge the company's financial health.

N/A

Revenue Growth

Revenue growth is essential for assessing the company's ability to expand its services and maintain market share.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

DVA Q2-2026 Earnings Preview

Context

Company Snapshot

DaVita Inc. is a leading provider of kidney care services, primarily through dialysis centers. As part of the health care sector, it plays a crucial role in managing chronic kidney disease, which affects millions of patients in the U.S.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+3.03%

Avg Stock Reaction

+0.92%

Last Quarter Recap

In Q1-2026, DaVita reported an EPS of $2.87, exceeding expectations by 19.09%. The stock reacted positively, gaining 1.92% the following day.

Management Promises & Guidance

Focus on improving patient care and outcomes.
Commitment to expanding dialysis services in underserved areas.
Plans to enhance operational efficiency.

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of the earnings report, especially after a strong performance last quarter. However, uncertainty remains due to the lack of analyst estimates.

Bull Case

If DaVita continues its trend of beating EPS estimates, it could signal strong operational performance and patient growth.

Bear Case

Conversely, any signs of declining patient numbers or revenue could raise concerns about the company's growth trajectory.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the current patient count and how does it compare to previous quarters?

A stable or growing patient count is crucial for DaVita's revenue and overall health, especially in a competitive market.

What are the company's plans for expanding services in underserved areas?

Expansion plans could indicate growth potential and management's commitment to improving access to care.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the impact of DaVita's recent operational improvements and patient care initiatives, which could drive better-than-expected results.

Supporting Evidence

DaVita has consistently beaten EPS estimates in recent quarters, suggesting strong management execution.

The options market is pricing in a large move, indicating that investors are anticipating significant news.

Recent trends in chronic kidney disease management show increasing demand for dialysis services.

Key Risk

If patient growth exceeds expectations, it could significantly alter the market's perception of DaVita's growth potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter, the focus is on patient growth and service expansion, which are critical for sustaining revenue.

Bull Confirmed If

A patient count increase of 5% or more compared to the previous quarter would confirm the bull case.

Bear Confirmed If

A decline in patient numbers or negative guidance would support the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±19.68%

Historical Avg

±1.5%

Pricing rich

The options market is pricing in a significant potential move, indicating heightened uncertainty or anticipation surrounding the earnings report.

Options are pricing ±19.7% while DVA has averaged ±1.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

65.2%

Calls (38K)P/C Ratio: 0.55Puts (4K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If DaVita beats expectations, history suggests a potential stock increase of around 1.48%, confirming strong operational performance.

In-Line / Cautious

An in-line report could lead to a muted reaction, as investors await more clarity on future growth.

Miss

A miss could result in a decline, with history indicating an average drop of 0.78% when expectations are not met.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Details on patient growth and retention rates.
2Updates on expansion plans in underserved regions.
3Any changes in operational efficiency metrics.
4Insights into competitive pressures in the dialysis market.
5Management's outlook on future revenue growth.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

DaVita Inc. is a leading provider of kidney care services, primarily through dialysis centers....

Key Metrics to Watch

EPS (Earnings Per Share)

EPS is a key indicator of profitability and helps investors gauge the company's financial health.

N/A

Revenue Growth

Revenue growth is essential for assessing the company's ability to expand its services and maintain market share.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

DVA Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+3.03%

Avg Stock Reaction

+0.92%

Last Quarter Recap

In Q1-2026, DaVita reported an EPS of $2.87, exceeding expectations by 19.09%. The stock reacted positively, gaining 1.92% the following day.

Management Promises & Guidance

Focus on improving patient care and outcomes.
Commitment to expanding dialysis services in underserved areas.
Plans to enhance operational efficiency.

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of the earnings report, especially after a strong performance last quarter. However, uncertainty remains due to the lack of analyst estimates.

Bull Case

If DaVita continues its trend of beating EPS estimates, it could signal strong operational performance and patient growth.

Bear Case

Conversely, any signs of declining patient numbers or revenue could raise concerns about the company's growth trajectory.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the current patient count and how does it compare to previous quarters?

A stable or growing patient count is crucial for DaVita's revenue and overall health, especially in a competitive market.

What are the company's plans for expanding services in underserved areas?

Expansion plans could indicate growth potential and management's commitment to improving access to care.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the impact of DaVita's recent operational improvements and patient care initiatives, which could drive better-than-expected results.

Supporting Evidence

DaVita has consistently beaten EPS estimates in recent quarters, suggesting strong management execution.

The options market is pricing in a large move, indicating that investors are anticipating significant news.

Recent trends in chronic kidney disease management show increasing demand for dialysis services.

Key Risk

If patient growth exceeds expectations, it could significantly alter the market's perception of DaVita's growth potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter, the focus is on patient growth and service expansion, which are critical for sustaining revenue.

Bull Confirmed If

A patient count increase of 5% or more compared to the previous quarter would confirm the bull case.

Bear Confirmed If

A decline in patient numbers or negative guidance would support the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±19.68%

Historical Avg

±1.5%

Pricing rich

The options market is pricing in a significant potential move, indicating heightened uncertainty or anticipation surrounding the earnings report.

Options are pricing ±19.7% while DVA has averaged ±1.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

65.2%

Calls (38K)P/C Ratio: 0.55Puts (4K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If DaVita beats expectations, history suggests a potential stock increase of around 1.48%, confirming strong operational performance.

In-Line / Cautious

An in-line report could lead to a muted reaction, as investors await more clarity on future growth.

Miss

A miss could result in a decline, with history indicating an average drop of 0.78% when expectations are not met.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Details on patient growth and retention rates.
2Updates on expansion plans in underserved regions.
3Any changes in operational efficiency metrics.
4Insights into competitive pressures in the dialysis market.
5Management's outlook on future revenue growth.